A new Market Authorisation for Rhei Life’s OTC medicine Metaspon has been granted to JGL company in Croatia by HALMED.

Metaspon medicine is indicated for the treatment of osteoartitis.
It is 4thRhei Life product to be launched in cooperation with JGL Croatia.

It is the 4th Rhei Life product to be launched in cooperation with JGL Croatia.

The Metaspon project is developed in partnership and license deal with Reig Jofre Company, contract manufacturing partner from Spain.